Clinical Trials Browser

Adenocarcinoma × oregovomab × Clear all

NCT01616303 2020-09-14

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Phase 2 Completed

Adenocarcinoma, Neoplasms, Ovarian Neoplasms